Showing 3501-3520 of 8875 for: Cochrane Systematic Reviews Back
- Immunoglobulin for alloimmune hemolytic disease in neonates
Cochrane Systematic Reviews, 18-Mar-2018
Exchange transfusion and phototherapy have traditionally been used to treat jaundice and avoid the associated neurological complications. Because of the risks and burdens of exchange transfusion, intravenous immunoglobulin (IVIg) has been suggested as an
- Immunoglobulin for multifocal motor neuropathy
Cochrane Systematic Reviews, 11-Jan-2022
Multifocal motor neuropathy (MMN) is a rare, probably immune-mediated disorder characterised by slowly progressive, asymmetric, distal weakness of one or more limbs with no objective loss of sensation. It may cause prolonged periods of disability. Treatme
- Immunoglobulin for preventing respiratory syncytial virus infection
Cochrane Systematic Reviews, 16-Jun-2008
Respiratory Syncytial virus, the most important cause of lower respiratory tract infections in infants and young children in industrialized countries, is associated with increased morbidity in premature infants with or without bronchopulmonary dysplasia a
- Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation
Cochrane Systematic Reviews, 8-Oct-2008
Patients undergoing hematopoietic stem cell transplantation (HSCT) and those with lymphoproliferative disorders (LPD) have a higher incidence of infections due to secondary hypogammaglobulinemia. One approach is the prophylactic administration of intraven
- Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection
Cochrane Systematic Reviews, 26-Aug-2019
Millions of children are hospitalised due to respiratory syncytial virus (RSV) infection every year. Treatment is supportive, and current therapies (e.g. inhaled bronchodilators, epinephrine, nebulised hypertonic saline, and corticosteroids) are ineffecti
- Immunoglobulins for preventing hepatitis A
Cochrane Systematic Reviews, 15-Apr-2009
Hepatitis A (infectious hepatitis) is a common epidemic disease. Immunoglobulins for passive immunisation are used as prevention.
- Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients
Cochrane Systematic Reviews, 17-Mar-2010
Cytomegalovirus (CMV) is the most common virus causing disease and death in solid organ transplant recipients during the first six months post-transplant. Previous systematic reviews have demonstrated the efficacy of antiviral medications used prophylacti
- Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis
Cochrane Systematic Reviews, 17-May-2013
Different therapeutic strategies are available for treatment of multiple sclerosis (MS) including immunosuppressants, immunomodulators, and monoclonal antibodies. Their relative effectiveness in the prevention of relapse or disability progression is uncle
- Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis
Cochrane Systematic Reviews, 16-Sep-2015
Different therapeutic strategies are available for the treatment of people with relapsing-remitting multiple sclerosis (RRMS), including immunomodulators, immunosuppressants and biologics. Although there is consensus that these therapies reduce the freque
- Immunomodulatory interventions for focal epilepsy syndromes
Cochrane Systematic Reviews, 26-Jun-2013
Epilepsy is a common neurological disorder made particularly disabling in the 30% of patients who do not achieve freedom from seizures despite multiple trials of antiepileptic drugs (AEDs). Experimental and clinical evidence supports a role for inflammato
- Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy
Cochrane Systematic Reviews, 8-May-2017
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a disease that causes progressive or relapsing and remitting weakness and numbness. It is probably caused by an autoimmune process. Immunosuppressive or immunomodulatory drugs would be ex
- Immunonutrition as an adjuvant therapy for burns
Cochrane Systematic Reviews, 23-Dec-2014
With burn injuries involving a large total body surface area (TBSA), the body can enter a state of breakdown, resulting in a condition similar to that seen with severe lack of proper nutrition. In addition, destruction of the effective skin barrier leads
- Immunonutrition for acute respiratory distress syndrome (ARDS) in adults
Cochrane Systematic Reviews, 24-Jan-2019
Acute respiratory distress syndrome (ARDS) is an overwhelming systemic inflammatory process associated with significant morbidity and mortality. Pharmacotherapies that moderate inflammation in ARDS are lacking. Several trials have evaluated the effects of
- Immunonutrition for patients undergoing surgery for head and neck cancer
Cochrane Systematic Reviews, 30-Aug-2018
Patients with head and neck cancer are often malnourished. Surgery for such cancers is complex and may be undertaken after a course of radiotherapy. As a result, patients may have postoperative complications such as fistulae and wound infections, as well
- Immunostimulants for preventing respiratory tract infection in children
Cochrane Systematic Reviews, 18-Oct-2006
Acute respiratory tract infections (ARTIs) are a major cause of childhood morbidity and mortality. Immunostimulants (IS) may reduce the incidence of ARTIs.
- Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 14-Nov-2022
Individuals with chronic obstructive pulmonary disease (COPD) or chronic bronchitis may experience recurrent exacerbations, which negatively impact prognosis and quality of life, and can impose a significant socioeconomic burden on the individual and wide
- Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis
Cochrane Systematic Reviews, 15-Aug-2012
Idiopathic inflammatory myopathies are chronic diseases with significant mortality and morbidity. Whilst immunosuppressive and immunomodulatory therapies are frequently used, the optimal therapeutic regimen remains unclear. This is an update of a review f
- Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy
Cochrane Systematic Reviews, 4-Mar-2015
Multifocal motor neuropathy (MMN) is characterised by progressive, predominantly distal, asymmetrical limb weakness and usually multiple partial motor nerve conduction blocks. Intravenous immunoglobulin (IVIg) is beneficial but the role of immunosuppressi
- Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty
Cochrane Systematic Reviews, 25-Aug-2015
Penetrating keratoplasty is a corneal transplantation procedure in which a full-thickness cornea from the host is replaced by a graft from a donor. The use of various immunosuppressants to prevent graft rejection, the most common cause of graft failure in
- Immunosuppressive agents for myasthenia gravis
Cochrane Systematic Reviews, 2-Nov-2008
The benefits of different immunosuppressants for myasthenia gravis (MG) are unclear.
